Enhanced FOXO1 expression as a predictor of decitabine response and prolonged survival in high-risk myelodysplastic syndrome
Purpose The aim of this study was to assess the predictive role of FOXO1 expression changes in determining the response to hypomethylation therapy in patients with high-risk myelodysplastic syndrome (MDS).Methods FOXO1 mRNA levels were measured using real-time PCR in 62 newly diagnosed MDS patients...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2025-12-01
|
| シリーズ: | Hematology |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/16078454.2025.2506862 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|